✨ Medicines Distribution Consents
NEW ZEALAND GAZETTE
No. 159
Provisional Consent to the Distribution of New Medicines
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Rapamune
Active Ingredient(s):
Sirolimus 1mg
Dosage Form:
Tablet
New Zealand Sponsor:
Wyeth (NZ) Limited
Manufacturer(s):
Ayerst Laboratories, Division of Wyeth-Ayerst Pharmaceuticals Inc, Rouses Point, New York, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product:
Zerit
Active Ingredient(s):
Stavudine 15mg
Dosage Form:
Capsule
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product:
Zerit
Active Ingredient(s):
Stavudine 20mg
Dosage Form:
Capsule
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product:
Zerit
Active Ingredient(s):
Stavudine 30mg
Dosage Form:
Capsule
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product:
Zerit
Active Ingredient(s):
Stavudine 40mg
Dosage Form:
Capsule
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product:
Zerit
Active Ingredient(s):
Stavudine 1mg/mL
Dosage Form:
Powder for oral solution
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer(s):
Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 15th day of November 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go8139
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo-Betaxolol
Active Ingredient(s):
Betaxolol hydrochloride 5.6mg/mL equivalent to 0.5% betaxolol base
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Novex Pharma Inc, Richmond Hill, Ontario, Canada
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 159
Gazette.govt.nz —
NZ Gazette 2001, No 159
✨ LLM interpretation of page content
🏥
Provisional Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare15 November 2001
Medicines Act 1981, Provisional Consent, Distribution, New Medicines, Rapamune, Zerit
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare15 November 2001
Medicines Act 1981, Consent, Distribution, New Medicines, Apo-Betaxolol
- G. R. Boyd, Chief Advisor, Safety and Regulation